Balasis, M., Forinash, K., Chen, Y., Fulp, W., Coppola, D., Hamilton, A., . . . Sebti, S. (2011). Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.
Cita Chicago (17th ed.)Balasis, M., K. Forinash, Y. Chen, W. Fulp, D. Coppola, A. Hamilton, J. Cheng, i S. Sebti. Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice. 2011.
Cita MLA (9th ed.)Balasis, M., et al. Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice. 2011.
Atenció: Aquestes cites poden no estar 100% correctes.